From Vision to Impact: How ScreenIT Is Transforming Brain Health Data
By Associate Professor James McLoughlin, Chief Academic & Founder at Your Brain Health
In 2022, Your Brain Health (YBH) was in its embryonic stages as an organisation. At that time, we held clear ambitions to promote a multimodal, community‑focused approach to brain health. By combining clinical experience, domain expertise, and emerging technologies, our goal was to enable better, evidence‑informed care.
We recognised an urgent need for integrated brain‑health solutions across diverse settings—concussion, mental health, ageing, and neurorehabilitation. This vision became the foundation for developing digital tools and clinical pathways that empower both healthcare professionals and the people they serve.
YBH was born from the belief that optimal outcomes are achieved when brain health is assessed and managed using a collaborative, multidisciplinary, and data‑driven model. From this initial vision, our future direction began to take shape.
In 2023, we expanded our work by creating and updating educational resources in partnership with global leaders in concussion care. At the same time, we responded to growing demand for multimodal baseline concussion screening in sporting clubs and schools, particularly in Australia and South Africa. Combined with education and clinical support, baseline testing became a key strategy for organisations seeking to engage with rising standards of care. Evidence supporting baseline screening was building, demonstrating that the process is more than the sum of its parts. Despite this, logistical barriers such as limited resources and cost remained significant. For example, in March 2024 the AFL Community Concussion Guidelines in Australia stated that “Baseline testing can be useful but is often time‑consuming and expensive.”
By this point, YBH had addressed part of the problem: baseline screens of online surveys and key objective tests had become efficient, affordable, and informative even for large groups, thanks to new assessment technologies. More clinics were partnering with us to provide an end‑to‑end solution—baseline screens, follow‑up assessments, and rehabilitation—for people who had sustained concussion. Nonetheless, multimodal screens still needed to become more streamlined, combining diverse tests into clear clinical reports and tracking recovery over time. Longitudinal brain‑health monitoring was also an unmet need, both for personalised care and for high‑priority research.
Driven by this unmet need and our clinical insights, we developed ScreenIT software to address these challenges. ScreenIT is designed to:
Easily capture previously fragmented data from validated questionnaires and objective multimodal outcome measures, alongside emerging assessment technologies. A selection of trusted tools allowing for clinician choice and autonomy to suit their contextual needs.
Automate comprehensive reports within seconds, saving administrative time.
Track measures longitudinally with intuitive timeline graphs.
Support clinics, clubs, and organisations through flexible permission structures for clinical and administrative staff, enhancing multidisciplinary collaboration.
Securely store a scalable, real‑world longitudinal database that can power future research and AI/machine‑learning insights.
We are excited to announce the release of ScreenIT in July 2025. This early version aims to meet the clinical needs of our first adopters in elite sports and community-based concussion care. We are proud to work with some of the world’s leading sporting organisations to ensure ScreenIT evolves to meet their specific requirements, including performance optimisation. At the same time, we feel a deep responsibility to include measures that are relevant for other populations, where brain health screening for concussion, healthy ageing, falls, frailty, functional decline, and modifiable risk factors linked to dementia and other neurodegenerative diseases is critically needed.
Brain health screening has shifted from a ‘strongly recommended’ option to an ‘expected requirement.’ At release, ScreenIT includes approved digital Concussion in Sports Group tools such as the SCAT6® and the first ever digital SCOAT6® at no additional cost. It also integrates a growing list of many validated assessment tools and technologies to further enhance your clinical practice needs and reputation.
We look forward to ScreenIT becoming an integral part of Your Brain Health’s mission to support best-practice care.